Trials / Completed
CompletedNCT04604158
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
IIT2020-13-GRESHAM-ELLY: Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Gillian Gresham · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-arm, prospective, interventional study in cancer survivors and patients to examine the feasibility of a mobile health application, Elly (Elly Health Inc.), to reduce levels of anxiety, stress, loneliness, and social isolation. Participants will be given access to the Elly phone application developed by Elly Health Inc. and will be asked to complete questionnaires measuring quality of life at multiple timepoints during the study.
Conditions
- Cancer
- Cancer Metastatic
- Neoplasms
- Breast Cancer
- Lung Cancer
- Glioblastoma
- Prostate Cancer
- Gynecologic Cancer
- Colorectal Cancer
- Sarcoma
- Kidney Cancer
- Bladder Cancer
- Lymphoma
- Leukemia
- Head and Neck Cancer
- Pancreas Cancer
- Multiple Myeloma
- Anxiety
- Social Isolation
- Stress
- Loneliness
- Melanoma
- Uterine Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Elly Mobile Phone Application | The Elly mobile phone application delivers daily audio recording aimed at reducing anxiety, stress, loneliness, and social isolation. |
Timeline
- Start date
- 2020-12-02
- Primary completion
- 2024-05-17
- Completion
- 2024-05-17
- First posted
- 2020-10-27
- Last updated
- 2024-05-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04604158. Inclusion in this directory is not an endorsement.